Skip to content
Research Article Open access CC BY 3.0

Role of Platelets Rich Plasma in Management of Osteoporotic Fractures

Ajai Singh, Sabir Ali, Abbas Ali Mahdi, Rajeshwar Nath Srivastava

Annual Research & Review in Biology · pp. 1187–1210 · Published 2 Jan 2014

10.9734/ARRB/2014/6130

Abstract

Management of osteoporotic fracture is challenging. In most clinical settings, skeletal regenerations are biologically optimized, but still many patients continue to experience delayed or impaired healing. Methods to enhance these healing processes, are needed to decrease patient’s agony, so that they can return to their work and regain their socioeconomic status in the community. Till this time, autologous bone grafting remain the standard procedure against which all new technologies are compared and analyzed.The success rate of union even after these grafts varies between 80-85% which further becomes decreased in case of repeated bone graft surgeries with donor site morbidities. Considering the concept that the healing of fracture started as soon as the formation of fracture clot, several investigators have suggested that degranulation of platelets at fracture clot elaborates the bioactive component, that aided the healing process. Because autologous platelet rich plasma products are safe and easy to prepare and administer, in this review, we reviewed the role of bioactive component released by activated platelet rich plasma in the fracture healing process and hypothesized that by combining the advantages of autologous bone grafts with autologous platelets concentrate, better and prompt results in orthopedic trauma managements can be obtained. We also observe that the use of these bioactive factors to enhance skeletal repair/healing represents the future of skeletal trauma management.

Osteoporotic fracture fragility fractures bone grafting platelets bioactivity Non-unions platelet rich plasma

References (198)

  1. 1 Platelet-rich plasma [DOI]
  2. 2 World-wide Projections for Hip Fracture [DOI]
  3. 3 Platelets and the immune continuum [DOI]
  4. 4 The Cell and Molecular Biology of Fracture Healing [DOI]
  5. 5 TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation [DOI]
  6. 6 Growth Factor Regulation of Fracture Repair [DOI]
  7. 7 Principles of bone healing [DOI]
  8. 8 Tissue Engineering of Bone: Material and Matrix Considerations [DOI]
  9. 9 Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program [DOI]
  10. 10 Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction [DOI]
  11. 11 Proteomic analysis of platelet α‐granules using mass spectrometry [DOI]
  12. 12 Platelet Dense Granules [DOI]
  13. 13 Fracture healing in osteoporotic fractures: Is it really different? [DOI]
  14. 14 Platelet-rich plasma in burns [DOI]
  15. 15 Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series.
  16. 16 Platelet-Rich Plasma Treatment for Ligament and Tendon Injuries [DOI]
  17. 17 Platelet-Rich Plasma Combined with Fractional Laser Therapy for Skin Rejuvenation [DOI]
  18. 18 Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes [DOI]
  19. 19 Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro [DOI]
  20. 20 Shedding light in the controversial terminology for platelet‐rich products: Platelet‐rich plasma (PRP), platelet‐rich fibrin (PRF), platelet‐leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism [DOI]
  21. 21 Effects of platelet‐derived growth factor on bone formation in vitro [DOI]
  22. 22 Growth factors in bone [DOI]
  23. 23 Expression of four growth factors during fracture repair [DOI]
  24. 24 Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor.
  25. 25 The Potential Role of Transforming Growth Factor Beta in Fracture Healing [DOI]
  26. 26 Iliac crest bone grafting and herbert screw fixation of nonunions of the scaphoid with avascular proximal poles [DOI]
  27. 27 The functional role of blood platelet components in angiogenesis [DOI]
  28. 28 Fractures of the Distal Femur Revisited [DOI]
  29. 29 Preparation, storage and quality control of platelet concentrates [DOI]
  30. 30 Platelet function in patients with major depression [DOI]
  31. 31 Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide [DOI]
  32. 32 HA-coated Screws Decrease the Incidence of Fixation Failure in Osteoporotic Trochanteric Fractures [DOI]
  33. 33 Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells [DOI]
  34. 34 Platelet-rich Plasma Promotes Healing of Osteoporotic Fractures [DOI]
  35. 35 Biomechanical Evaluation of the Schuhli Nut [DOI]
  36. 36 The Effect of Augmentation With Resorbable or Conventional Bone Cement on the Holding Strength for Femoral Neck Fracture Devices [DOI]
  37. 37 Blade plate fixation of proximal humeral non-unions [DOI]
  38. 38 Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta [DOI]
  39. 39 The Effect of Subconjunctival Platelet-Rich Plasma on Corneal Epithelial Wound Healing [DOI]
  40. 40 5-HT and bone biology [DOI]
  41. 41 Isoflavones extracted fromsophorae fructus upregulate IGF-I and TGF-β and inhibit osteoclastogenesis in rat born marrow cells [DOI]
  42. 42 Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests [DOI]
  43. 43 Can autologous thrombin with a rest fraction of ethanol be used safely for activation of concentrated autologous platelets applied on nerves? [DOI]
  44. 44 Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone [DOI]
  45. 45 Effects of transforming growth factor-β deficiency on bone development: A Fourier Transform-Infrared imaging analysis [DOI]
  46. 46 Osteoporosis in Men—Consensus is Premature [DOI]
  47. 47 Ovariectomy Decreases the mRNA Levels of Transforming Growth Factor-β1 and Increases the mRNA Levels of Osteocalcin in Rat Bone in Vivo [DOI]
  48. 48 Stimulation of Bone Formation In Vivo by Insulin-Like Growth Factor-II in Rats [DOI]
  49. 49 The use of a resorbable augmentation device to secure plating of osteoporotic bones [DOI]
  50. 50 Applied therapeutics; the clinical use of drugs [DOI]
  51. 51 Platelet α-granules: Basic biology and clinical correlates [DOI]
  52. 52 Age-Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone Marrow [DOI]
  53. 53 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β [DOI]
  54. 54 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells [DOI]
  55. 55 The platelet release reaction: granules' constituents, secretion and functions [DOI]
  56. 56 Platelets: signaling cells in the immune continuum [DOI]
  57. 57 Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons [DOI]
  58. 58 Temporal growth factor release from platelet‐rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression [DOI]
  59. 59 Age-related changes in osteogenic stem cells in mice [DOI]
  60. 60 Measurement and significance of three-dimensional architecture to the mechanical integrity of trabecular bone [DOI]
  61. 61 The evolving role of platelets in inflammation [DOI]
  62. 62 Platelet Rich Concentrate: Basic Science and Current Clinical Applications [DOI]
  63. 63 Role of Adult Mesenchymal Stem Cells in Bone Tissue Engineering Applications: Current Status and Future Prospects [DOI]
  64. 64 Use of Autologous Platelet-Rich Plasma in the Treatment of Dormant Corneal Ulcers [DOI]
  65. 65 The emerging role of platelets in adaptive immunity [DOI]
  66. 66 Platelets and Psychiatry: Lessons Learned From Old and New Studies [DOI]
  67. 67 Effect of neural‐induced mesenchymal stem cells and platelet‐rich plasma on facial nerve regeneration in an acute nerve injury model [DOI]
  68. 68 Bone Mineral and Collagen Quality in Iliac Crest Biopsies of Patients Given Teriparatide: New Results from the Fracture Prevention Trial [DOI]
  69. 69 Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats [DOI]
  70. 70 Platelet-Rich Plasma: A Literature Review [DOI]
  71. 71 An Evidence-Based Model Comparing the Cost-effectiveness of Platelet-Rich Plasma Gel to Alternative Therapies for Patients with Nonhealing Diabetic Foot Ulcers [DOI]
  72. 72 Modulation of Transforming Growth Factor-βProduction in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone [DOI]
  73. 73 Growth factors and cutaneous wound repair [DOI]
  74. 74 Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures [DOI]
  75. 75 Healing Complications After Internal Fixation of Trochanteric Hip Fractures: The Prognostic Value of Osteoporosis [DOI]
  76. 76 TGF-β1 as a marker of delayed fracture healing [DOI]
  77. 77 Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis [DOI]
  78. 78 Risks of using platelet rich plasma gel [DOI]
  79. 79 In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage [DOI]
  80. 80 Platelets and Endothelial Cells [DOI]
  81. 81 Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption [DOI]
  82. 82 The potential of gene therapy for fracture healing in osteoporosis [DOI]
  83. 83 Prevention of Hip Lag Screw Cut-Out by Cement Augmentation: Description of a New Technique and Preliminary Clinical Results [DOI]
  84. 84 An injectable cementing screw for fixation in osteoporotic bone [DOI]
  85. 85 Insights into the Platelet Releasate [DOI]
  86. 86 Phase I/II prospective trial of autologous platelet tissue graft in gynecologic surgery [DOI]
  87. 87 Angiogenic Growth Factors: Their Effects and Potential in Soft Tissue Wound Healing [DOI]
  88. 88 A Comparative Study of Bilateral Sinus Lifts Performed with Platelet-Rich Plasma Alone Versus Alloplastic Graft Material Reconstituted with Blood [DOI]
  89. 89 Cemented Internal Fixation for Supracondylar Femur Fractures in Osteoporotic Patients [DOI]
  90. 90 Hip Screw Augmentation with an In Situ-Setting Calcium Phosphate Cement: An In Vitro Biomechanical Analysis [DOI]
  91. 91 Local application of rhTGF-β2 enhances peri-implant bone volume and bone-implant contact in a rat model [DOI]
  92. 92 Inhibition of oxidative-stress-induced platelet aggregation by androgen at physiological levels via its receptor is associated with the reduction of thromboxane A2 release from platelets [DOI]
  93. 93 Platelet rich plasma improves the healing process after airway anastomosis, [DOI]
  94. 94 Effect of Estrogen on the Activity and Growth of Human Osteoclasts In Vitro [DOI]
  95. 95 Use of topical recombinant human platelet–derived growth factor BB in abdominal wound separation [DOI]
  96. 96 Modulation of platelet activation and initial cytokine release by alloplastic bone substitute materials [DOI]
  97. 97 Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses [DOI]
  98. 98 Interactions of Growth Factors Present in Bone Matrix with Bone Cells: Effects on DNA Synthesis and Alkaline Phosphatase [DOI]
  99. 99 Transforming growth factor-β modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages [DOI]
  100. 100 Schraubenhalt-Verstärkung im Femurkopf durch Zementapplikation via Implantat - eine biomechanische Studie [DOI]
  101. 101 Platelet-Rich Plasma [DOI]
  102. 102 The biology of fracture healing in long bones [DOI]
  103. 103 Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration [DOI]
  104. 104 Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure [DOI]
  105. 105 Platelets: Physiology and Biochemistry [DOI]
  106. 106 The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery [DOI]
  107. 107 Regulatory Effects of Insulin-Like Growth Factors I and II on Bone Collagen Synthesis in Rat Calvarial Cultures* [DOI]
  108. 108 Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes [DOI]
  109. 109 Platelet-derived growth factors enhance proliferation of human stromal stem cells [DOI]
  110. 110 Treatment of Knee Joint Osteoarthritis with Autologous Platelet-Rich Plasma in Comparison with Hyaluronic Acid [DOI]
  111. 111 Autologous Platelet-Rich Plasma: A Potential Therapeutic Tool for Promoting Hair Growth [DOI]
  112. 112 Osteoporosis influences the early period of fracture healing in a rat osteoporotic model [DOI]
  113. 113 Pre- and Postmenopausal Women Have Different Bone Mineral Density Responses to the Same High-Impact Exercise [DOI]
  114. 114 Roles of Autocrine TGF-β Receptor and Smad Signaling in Adipocyte Differentiation [DOI]
  115. 115 Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration [DOI]
  116. 116 A Systematic Review of the Use of Platelet-Rich Plasma in Sports Medicine as a New Treatment for Tendon and Ligament Injuries [DOI]
  117. 117 The Calcium-Sensing Receptor: A Molecular Perspective [DOI]
  118. 118 Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats [DOI]
  119. 119 Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study [DOI]
  120. 120 Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells underin vitroconditions [DOI]
  121. 121 Platelet–lymphocyte cross-talk [DOI]
  122. 122 Proteomic and Phospho-Proteomic Profile of Human Platelets in Basal, Resting State: Insights into Integrin Signaling [DOI]
  123. 123 Formulation and Storage of Platelet-Rich Plasma Homemade Product [DOI]
  124. 124 The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis [DOI]
  125. 125 Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. [DOI]
  126. 126 The Results of Open Reduction and Internal Fixation of Distal Femur Fractures Using a Biologic (Indirect) Reduction Technique [DOI]
  127. 127 Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7 [DOI]
  128. 128 Comparison of Platelet‐Rich Plasma, Bovine Porous Bone Mineral, and Guided Tissue Regeneration Versus Platelet‐Rich Plasma and Bovine Porous Bone Mineral in the Treatment of Intrabony Defects: A Reentry Study [DOI]
  129. 129 Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts [DOI]
  130. 130 Distal femoral fractures: long-term outcome following stabilisation with the LISS [DOI]
  131. 131 The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone [DOI]
  132. 132 Backgrounds of the technology of internal fixators [DOI]
  133. 133 Platelet CD40L at the interface of adaptive immunity [DOI]
  134. 134 uPA deficiency exacerbates muscular dystrophy in MDX mice [DOI]
  135. 135 Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence [DOI]
  136. 136 Platelet rich therapies for long bone healing in adults [DOI]
  137. 137 Preclinical and Clinical Studies on the Use of Growth Factors for Bone Repair: A Systematic Review [DOI]
  138. 138 Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats [DOI]
  139. 139 Pilot Study on the Efficiency of the Biostimulation with Autologous Plasma Rich in Platelet Growth Factors in Otorhinolaryngology: Otologic Surgery (Tympanoplasty Type I) [DOI]
  140. 140 The effect of platelet‐rich plasma upon implant stability measured by resonance frequency analysis in the lower anterior mandibles [DOI]
  141. 141 Fracture Healing in Mice Deficient in Plasminogen Activator Inhibitor-1 [DOI]
  142. 142 Platelet‐rich plasma activation in combination with biphasic osteochondral scaffolds–conditions for maximal growth factor production [DOI]
  143. 143 Exercise and training effects on platelets in health and disease [DOI]
  144. 144 Successful treatment of premature rupture of membranes after genetic amniocentesis by intra‐amniotic injection of platelets and cryoprecipitate (amniopatch): a case report [DOI]
  145. 145 Tratamiento de úlcera corneal neurotrófica con plasma rico en plaquetas y Tutopatch® [DOI]
  146. 146 Bone Healing with or without Platelet‐Rich Plasma around Four Different Dental Implant Surfaces in Beagle Dogs [DOI]
  147. 147 Influence of platelet-rich plasma on proliferation and osteogenic differentiation of skeletal muscle satellite cells: An in vitro study [DOI]
  148. 148 Mesh Fixation with Autologous Platelet-Rich Fibrin Sealant in Inguinal Hernia Repair [DOI]
  149. 149 Non-union in fractures of the humeral shaft [DOI]
  150. 150 Die Rolle von Thrombozyten bei Hämostase, Thrombose, Immunabwehr und Entzündung [DOI]
  151. 151 Evolution of the internal fixation of long bone fractures: The scientific basis of biological internal fixation: choosing a new balance between stability and biology [DOI]
  152. 152 Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants.
  153. 153 Circulating levels of IGF-1 directly regulate bone growth and density [DOI]
  154. 154 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis [DOI]
  155. 155 Positive Effect of an Autologous Platelet Concentrate in Lateral Epicondylitis in a Double-Blind Randomized Controlled Trial [DOI]
  156. 156 Regulation of Fracture Repair by Growth Factors [DOI]
  157. 157 Role of platelet‐derived growth factor in wound healing [DOI]
  158. 158 Platelet‐Rich Plasma Intra‐Articular Injection Versus Hyaluronic Acid Viscosupplementation as Treatments for Cartilage Pathology: From Early Degeneration to Osteoarthritis [DOI]
  159. 159 Is platelet-rich plasma the perfect enhancement factor? A current review. [DOI]
  160. 160 Platelet-Rich Plasma Differs According to Preparation Method and Human Variability [DOI]
  161. 161 Molecular basis of anti‐inflammatory action of platelet‐rich plasma on human chondrocytes: Mechanisms of NF‐κB inhibition via HGF [DOI]
  162. 162 Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation [DOI]
  163. 163 HERBERT SCREW FIXATION OF SCAPHOID FRACTURES [DOI]
  164. 164 The Use of Platelet‐Rich Plasma in Arthroscopy and Sports Medicine: Optimizing the Healing Environment [DOI]
  165. 165 Platelet‐rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans [DOI]
  166. 166 Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent [DOI]
  167. 167 Brace Wear Control of Curve Progression in Adolescent Idiopathic Scoliosis [DOI]
  168. 168 The platelet proteome [DOI]
  169. 169 Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection [DOI]
  170. 170 Evidence on the use of platelet-rich plasma for diabetic ulcer: A systematic review [DOI]
  171. 171 [Growth factors and wound healing].
  172. 172 Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts [DOI]
  173. 173 Differential growth factor retention by platelet-rich plasma composites [DOI]
  174. 174 Platelet‐rich plasma may prevent titanium‐mesh exposure in alveolar ridge augmentation with anorganic bovine bone [DOI]
  175. 175 Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery.
  176. 176 Observations on Non-Union of the Shafts of the Long Bones, with a Statistical Analysis of 842 Patients [DOI]
  177. 177 Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts.
  178. 178 Abundant Retention and Release of Connective Tissue Growth Factor (CTGF/CCN2) by Platelets [DOI]
  179. 179 The Effects of Autologous Platelet Gel on Wound Healing [DOI]
  180. 180 Microarray analyses of transdifferentiated mesenchymal stem cells [DOI]
  181. 181 GERIATRIC TRAUMA [DOI]
  182. 182 Improvement of the Bone-Pin Interface Strength in Osteoporotic Bone with Use of Hydroxyapatite-Coated Tapered External-Fixation Pins [DOI]
  183. 183 Semitubular blade plate fixation in proximal humeral fractures: A biomechanical study in a cadaveric model [DOI]
  184. 184 Comminuted trochanteric femoral fractures in geriatric patients: the results of 231 cases treated with internal fixation and acrylic cement.
  185. 185 Delayed Union and Non-Union of Fractures [DOI]
  186. 186 Osteosynthesis and primary valgus intertrochanteric osteotomy in displaced intracapsular fracture neck of femur with osteoporosis in adults [DOI]
  187. 187 Biologisierung von Implantaten in der Chirurgie des St�tz- und Bewegungsapparates [DOI]
  188. 188 Postoperative Surgical Chest and Leg Incision Sites Using Platelet Gel: A Retrospective Study [DOI]
  189. 189 Plenary Lecture: Strategies for skeletal health in the elderly [DOI]
  190. 190 Acute Changes in Femoral Arterial Blood Flow after Closed Tibial Fracture in Dogs [DOI]
  191. 191 Schuhli Augmentation of Plate and Screw Fixation for Humeral Shaft Fractures: A Laboratory Study [DOI]
  192. 192 Comparative study of β-tricalcium phosphate mixed with platelet-rich plasma versus β-tricalcium phosphate, a bone substitute material in dentistry [DOI]
  193. 193 Effects of estrogen on the expression of TGF-B in early fracture healing of ovariectomized rats [DOI]
  194. 194 [Stimulation of bone formation].
  195. 195 Healing of Normal and Osteoporotic Bone [DOI]
  196. 196 A cement screw for fixation in osteoporotic metaphyseal bone
  197. 197 Is calcitonin useful for reducing pain of acute osteoporotic fracture? [DOI]
  198. 198 [Stress shielding and fracture healing].

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

59

Page views

0

PDF downloads

11

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.